Bromhexine hydrochloride + phenylbutazone is indicated for use in horses to relieve respiratory tract infections associated with mucus accumulation and pain and inflammation associated with musculoskeletal disorders such as arthritis and laminitis.

The dosage and administration of Bromhexine hydrochloride + phenylbutazone in horses should be determined by a veterinarian.

Adverse reactions may occur with the use of Bromhexine hydrochloride + phenylbutazone in horses. The most common side effects include:

• Gastric ulcers
• Loss of appetite
• Colic
• Diarrhea
• Muscle weakness
• Skin reactions
• Increased liver enzyme levels

Before administering Bromhexine hydrochloride + phenylbutazone to horses, the following precautions should be taken:

• The drug should not be used in pregnant or lactating mares.
• The drug should not be used in horses with a history of gastric ulcers, kidney disease, or liver disease.
• The drug should not be used in horses intended for human consumption.
• The drug should not be used in horses under 1 year of age.
• The drug should be used with caution in horses with a history of bleeding disorders or those taking other NSAIDs or corticosteroids.
• The drug should be used with caution in horses with a history of colic or gastrointestinal disorders.